Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Cash from Operations (2020 - 2025)

RxSight's Cash from Operations history spans 6 years, with the latest figure at 1116000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 73.8% year-over-year to 1116000.0; the TTM value through Dec 2025 reached 15511000.0, up 8.47%, while the annual FY2025 figure was 15511000.0, 8.47% up from the prior year.
  • Cash from Operations reached 1116000.0 in Q4 2025 per RXST's latest filing, up from 1187000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 650000.0 in Q3 2024 to a low of 17764000.0 in Q1 2023.
  • Average Cash from Operations over 5 years is 8880400.0, with a median of 8777000.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: skyrocketed 108.14% in 2024, then tumbled 282.62% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 8722000.0 in 2021, then tumbled by 58.84% to 13854000.0 in 2022, then soared by 40.08% to 8301000.0 in 2023, then soared by 48.68% to 4260000.0 in 2024, then surged by 73.8% to 1116000.0 in 2025.
  • Per Business Quant, the three most recent readings for RXST's Cash from Operations are 1116000.0 (Q4 2025), 1187000.0 (Q3 2025), and 4376000.0 (Q2 2025).